Amy Musiek

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott et al. · Blood · 2018 · 397 citations · Full text

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States

Robert G. Micheletti, Zelma C. Chiesa Fuxench, Megan H. Noe et al. · Journal of Investigative Dermatology · 2018 · 134 citations

Adult Patients, Surgical Pathology, Pathology +6

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10

Megan H. Noe, Misha Rosenbach, Rebecca A. Hubbard et al. · JAMA Dermatology · 2019 · 105 citations · Full text

Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus

Anniek Zaalberg, Sara Moradi Tuchayi, Amir H. Ameri et al. · Journal of Investigative Dermatology · 2018 · 49 citations · Full text

Inflammation, Autoimmune Disease, Lupus +9